Pharmaceutical supply chains are functioning, but they have not been fully optimized.

The "LogiPharma Playbook: 2026 Supply Chain & Logistics Insights," created by LogiPharma Insights with partners including Blue Yonder and GXO, provides an in-depth analysis of the pharmaceutical supply chain's current state and future challenges. It emphasizes the need for resilience amidst pressures from AI, systemic risks, and digital collaboration. While supply chains are functional, they require a shift from reactive to proactive decision-making. Key findings highlight issues like constrained hospital supply capabilities, cautious AI adoption, and the need for better digital integration, ultimately urging leaders to invest in data visibility and collaborative governance to enhance supply chain resilience.